Pan-cancer analysis identifies protein arginine methyltransferases PRMT1 and PRMT5 and their related signatures as markers associated with prognosis, immune profile, and therapeutic response in lung adenocarcinoma-Reference-Cited by-同舟云学术

Pan-cancer analysis identifies protein arginine methyltransferases PRMT1 and PRMT5 and their related signatures as markers associated with prognosis, immune profile, and therapeutic response in lung adenocarcinoma

Published:2023-12 Issue:12 Volume:9 Page:e22088
ISSN:2405-8440
Container-title:Heliyon
language:en
Short-container-title:Heliyon

Author:

Wang Jia,Wu Meng,Sun Jujie,Chen Minxin,Zhang Zengfu,Yu Jinming,Chen Dawei

Funder

National Natural Science Foundation of China

Natural Science Foundation of Shandong Province

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference52 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA;Sung;Cancer J. Clin.,2021

2. First-line immunotherapy for non-small-cell lung cancer;Reck;J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol.,2022

3. Protein arginine methyltransferases: promising targets for cancer therapy;Hwang;Exp. Mol. Med.,2021

4. Arginine methylation: the coming of age;Blanc;Mol. Cell.,2017

5. Inhibiting type I arginine methyltransferase activity promotes T cell-mediated antitumor immune responses;Fedoriw;Cancer Immunol. Res.,2022

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ferroptosis: Molecular perspective, cellular influence, cancer manifestation, and therapeutic potentials;Journal of Drug Delivery Science and Technology;2024-10

2. Identification of PRMT5 as a therapeutic target in cholangiocarcinoma;Gut;2024-09-11

3. A chemical screen identifies PRMT5 as a therapeutic vulnerability for paclitaxel-resistant triple-negative breast cancer;Cell Chemical Biology;2024-09

4. Targeting type I PRMTs as promising targets for the treatment of pulmonary disorders: Asthma, COPD, lung cancer, PF, and PH;Life Sciences;2024-04

5. Role and potential therapeutic value of histone methyltransferases in drug resistance mechanisms in lung cancer;Frontiers in Oncology;2024-03-08